Explore By Subject Area   

Immuno-Oncology 360°

Date: Mar 24, 2025 - Mar 26, 2025

Location: Boston, MA

2025 Sponsors

Featured Executive Sponsor
PredxBio 2025

PredxBio is a TechBio company, headquartered in Pittsburgh, harnessing the power of spatial biology to unravel the hidden circuitries of the tumor microenvironment and getting to the “Why?” of cancer. Demonstrating a clear impact today, we have established an impressive accuracy in predicting patient responses to immunotherapy across the most critical cancers. Our ground-breaking platform aims to transform cancer care with next generation spatial analytics and explainable AI, thereby accelerating advancements in drug development and clinical trials. PredxBio opens a new era with far-reaching implications for biomarker discovery and clinical research with promising results in understanding disease progression and response to therapy. For more information please reach us at info@predxbio.com

Associate Sponsors
Scimega
Scimega
Scimega is a niche Canadian oncology CRO acting in Canada within the context of global cutting-edge oncology trials sponsored by mid-size and smaller biotechs. Skilled in collaborative vendor teaming, Scimega guarantees sponsors the quickest...... Read More
TD2
TD2
TD2 provides innovative services for improved and accelerated development of medicines for cancer. Our team has deep experience and understanding in drug development. Preclinical development, combined with regulatory affairs expertise, guides customized clinical trial...... Read More
Voiant Clinical 2025
Voiant Clinical 2025
MedQIA, WorldCare Clinical and DARC, have come together to form Voiant, the industry’s leading clinical trial imaging solution provider with unparalleled scientific and clinical domain expertise. Voiant’s unique AI-based software platform integrates all aspects...... Read More
Supporting Sponsors
Elephas Biosciences
Elephas Biosciences
Elephas is developing an ex-vivo technology suite to assess how live tumor fragments (LTFs)TM respond to immunotherapies. We seek to remove the trial-and-error approach to cancer care by harnessing the latest advances in cancer...... Read More
Onc.AI
Onc.AI
Onc.AI is venture-capital backed company committed to developing robust, clinically validated, imaging-AI powered clinical management solutions focused on immunotherapy optimization. Using patented, radiomic-based AI models, Onc.AI has developed a clinical decision support platform using...... Read More
RareCyte
RareCyte
RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings...... Read More

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.